机译:抗体对于rVSV / ZEBOV-GP介导的针对非人类灵长类动物的致命埃博拉病毒攻击的保护是必需的
Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006;
Office of Operations Management, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239;
Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550,Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550;
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan,International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan,Exploratory Research for Advanced Technology Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama 332-0012, Japan;
Department of Microbiology, University of Washington, Seattle, WA 98195,Washington National Primate Research Center, University of Washington, Seattle, WA 98195;
Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006,Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239,Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR 97006;
机译:狂犬病病毒双价疫苗免疫的非人类灵长类动物的抗体质量和对致命埃博拉病毒攻击的防护
机译:表达蛋白酶等叶菌病毒的单剂量改性痘苗病毒,如颗粒保护来自致命埃博拉病毒攻击的非人的灵长类动物
机译:埃博拉病毒样颗粒疫苗可保护非人类灵长类动物免受致命的埃博拉病毒攻击
机译:r_2 *作为非洲原始工具中埃博拉病毒肝病进展的非侵入内源性成像生物标志物的评价
机译:埃博拉粘蛋白样结构域对埃博拉病毒样颗粒诱导的抗糖蛋白抗体的影响。
机译:抗体对于rVSV / ZEBOV-GP介导的针对非人类灵长类动物的致命埃博拉病毒攻击的保护是必需的
机译:RVSV / Zebov-GP介导的抗体是必需的,对非人灵长类动物的致死血栓病毒攻击是必要的